Stay updated on ABP798 vs Rituximab in NHL: Clinical Trial
Sign up to get notified when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.

Latest updates to the ABP798 vs Rituximab in NHL: Clinical Trial page
- ChecktodayChange Detected- Revision updated from v3.5.4 to v3.5.5, indicating a minor update to the page metadata. This update does not introduce visible content changes.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision tag changed from v3.5.3 to v3.5.4, indicating a minor update to the ClinicalTrials.gov record. There are no visible changes to the study content (inclusion/exclusion criteria, endpoints, or locations) in this update.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3 on the page, indicating a newer iteration. This is a minor update to the page's version and does not alter study content or how the page operates.SummaryDifference0.0%

- Check50 days agoChange DetectedSite revision updated to v3.5.2.SummaryDifference0.0%

- Check65 days agoChange DetectedPadua, Italy, 35128 was replaced with Padova, Italy, 35128 in the Locations section.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to ABP798 vs Rituximab in NHL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.